Coliprotec F4

RSS

Escherichia coli, type 08, strain K87 (live)

Withdrawn
This medicine is now withdrawn from use in the European Union.

Overview

The marketing authorisation for Coliprotec F4 has been withdrawn at the request of the marketing authorisation holder.

This EPAR was last updated on 23/11/2021

Authorisation details

Product details
Name
Coliprotec F4
Agency product number
EMEA/V/C/003797
Active substance
live non-pathogenic Escherichia coli O8:K87
International non-proprietary name (INN) or common name
Escherichia coli, type 08, strain K87 (live)
Species
Pigs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI09AE03
Publication details
Marketing-authorisation holder
Prevtec Microbia GmbH
Revision
2
Date of issue of marketing authorisation valid throughout the European Union
16/03/2015
Contact address
Geyerspergerstrasse 27
80689 München
Germany

Product information

15/01/2020 Coliprotec F4 - EMEA/V/C/003797 - R/0005

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

  • Immunologicals for suidae

  • Live bacterial vaccines
  • Pig

Therapeutic indication

For active immunisation of pigs against enterotoxigenic F4-positive Escherichia coli in order to:

  • reduce the incidence of moderate to severe post-weaning Escherichia coli diarrhoea (PWD) in pigs;
  • reduce the colonisation of the ileum and faecal shedding of enterotoxigenic F4-positive Escherichia coli from infected pigs.

Assessment history

How useful was this page?

Add your rating
Average
1 rating
1 rating